When Elena Ivanova first saw electron microscopy images of viral particles shredded on a sheet of plastic, she knew her team at RMIT University had crossed a threshold. “We have shown that a low-cost, scalable polymer surface can mechanically destroy viruses without any chemical assistance,” Ivanova, a distinguished professor in RMIT’s School of Science, said in a university statement accompanying the research. The images showed hPIV-3 particles visibly torn apart after landing on a thin acrylic film studded with thousands of nanoscale pillars, each so small that roughly 1,000 of them could fit across the width of a human hair.
The results, published in Advanced Science, show that the textured film inactivated human parainfluenza virus type 3 (hPIV-3) within one hour under laboratory conditions. Pillars spaced roughly 60 nanometers apart delivered the strongest kill rate. The work marks a significant leap from the team’s earlier silicon-based prototypes toward a material cheap and flexible enough for everyday products.
How nanopillars destroy a virus
Enveloped viruses, a category that includes influenza, RSV, and SARS-CoV-2, are wrapped in a fragile lipid membrane. That membrane is their armor: without it, the virus cannot latch onto and enter human cells. The RMIT film exploits that vulnerability through geometry alone.
When an enveloped virus settles onto the nanopillar array, the tiny columns press into and rupture the lipid layer. Electron microscopy images in the study show viral particles visibly torn apart after contact. Because the mechanism is purely mechanical, it does not weaken with repeated use the way chemical coatings do, and it cannot drive the kind of resistance that overuse of chemical disinfectants can promote.
The RMIT team found that pillar spacing was critical. At roughly 60 nanometers apart, the columns matched the scale of the viral envelope well enough to maximize damage. Wider spacing let viruses settle between pillars without sufficient contact, reducing effectiveness.
From silicon lab chips to mass-market plastic
The concept of killing pathogens with surface texture is not brand new at RMIT. An earlier prototype built on silicon nanospikes achieved what the university described as 96% inactivation of hPIV-3 particles. That figure comes from an RMIT news summary rather than the original peer-reviewed silicon study, so the precise number should be treated with that caveat in mind. Regardless, the silicon work, a collaboration with Spain’s Universitat Rovira i Virgili, proved the principle but ran into a practical wall: silicon nanospikes require expensive semiconductor-grade fabrication, making them impractical for large surfaces.
Acrylic changes the economics. The polymer can be textured using industrial processes such as hot embossing or injection molding, the same techniques already used to produce everything from car dashboards to smartphone cases. In principle, a manufacturer could stamp virus-killing texture onto plastic panels, protective films, or device housings at scale. The chemical-free approach also eliminates the supply-chain dependency on antimicrobial agents like silver ions or quaternary ammonium compounds, which must be periodically reapplied.
Where the science still has gaps
For all its promise, the acrylic film has been tested against only one virus so far. hPIV-3 is a reasonable laboratory stand-in for enveloped respiratory pathogens, but the study does not include results against SARS-CoV-2, influenza A, or RSV. Broader pathogen testing will be essential before any public health claims can be made. Background literature on the environmental stability of respiratory viruses, including a 2021 Lancet review, suggests the mechanical principle should apply to other enveloped viruses, but direct evidence is still needed.
Durability is another open question. Laboratory tests control for temperature, humidity, and contamination in ways that a hospital corridor or subway handrail does not. Oils from skin, cleaning products, dust, and UV exposure could all blunt or clog the nanopillars over time. None of the published data addresses how the film performs after weeks or months of real-world wear, and no field trials have been announced as of May 2026.
Cost remains undisclosed. The RMIT team has not published manufacturing estimates or announced partnerships with medical device companies, building material suppliers, or consumer product makers. The scalability argument in the paper rests on the choice of acrylic as a substrate and the compatibility of the nanofeatures with industrial molding, not on demonstrated factory output or pricing.
There is also no head-to-head comparison with existing antimicrobial surfaces. Copper alloys, for example, are already registered with the U.S. Environmental Protection Agency as antimicrobial materials and are used on high-touch fixtures in some hospitals. Silver-ion-treated plastics are another established option. Without direct benchmarking, it is impossible to say whether the nanopillar film would outperform, outlast, or undercut these alternatives on price.
What this could mean for public spaces
If the remaining questions can be answered, the potential applications are broad. Door handles, elevator buttons, hospital bed rails, airplane tray tables, and public transit grab bars are all high-touch surfaces where respiratory viruses can survive for hours on conventional smooth plastic. A self-sterilizing film that works passively, with no batteries, no refills, and no maintenance schedule, would be a meaningful upgrade over surfaces that rely on periodic manual disinfection.
Researchers have also floated the idea of integrating the texture into face masks, where it could neutralize trapped viral particles between uses. That application remains speculative; no mask prototypes have been described in the published literature.
A promising lab result awaiting real-world proof
For now, the RMIT acrylic film is a laboratory advance with a clear path toward practical use but several hurdles still in the way. The peer-reviewed data is solid: the nanopillars destroy an enveloped virus through physical force, and the mechanism works on a material suited to mass manufacturing. Turning that into a product people actually touch every day will require durability testing, broader pathogen validation, and a manufacturing partner willing to bet on a new approach to an old problem.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
